Eslidin caps. 30 pc

Description

Composition
Active substance:
1 capsule contains lipoid PPL-400 (phospholipids) (based on 100% content of polyunsaturated phospholipids of soy lecithin – PPL fraction) 300 mg methionine (in terms of 100% substance) 100 mg of soybean oil 550 mg.
Excipients:
Titanium dioxide, iron oxide black, iron oxide red, iron oxide yellow, purified water, gelatin.
Description:
Hard gelatin capsules body light brown and brown color cap. The contents of capsules – yellow-brown or brown homogeneous mass of a pasty to solid consistency with a characteristic odor.
Product form:
Eslidin® capsule 10 capsules in blisters of PVC film and aluminum foil. 30, 50, 60 or 100 capsules in polymeric jar. 30 capsules per jar of glass OC (amber glass) with a triangular whisk, 50 or 60 capsules in a glass jar with a screw neck. Each jar or 3 or 5 or 6 or 10, the contour of cellular packaging together with instructions for medical use of the formulation was put in a pile of cardboard.
Contraindications
Hypersensitivity (sensitivity) to the drug; severe liver failure, hepatic encephalopathy, viral hepatitis, children up to 3 years.
The caution can be applied during pregnancy and in children from 3 to 7 years old, as well as in renal failure (due to the risk of increase hyperasotemia).
Indications
The drug is used in gastroenterology, dermatology, neurology, cardiology.
Gastroenterology: Fatty Liver various etiology; acute and chronic hepatitis (viral apart); cirrhosis of the liver; toxic liver damage – alcohol, drug, drug; violation hepatocyte function (as a complication of other diseases); pre- and post-operative treatment during operations in the field of hepatobiliary zone.
Dermatology: Psoriasis in the complex therapy.
Neurology: Cerebral arteriosclerosis in the complex therapy.
Endocrinology: Diabetes in the complex therapy; depletion, degeneration.
Cardiology: Atherosclerosis of the coronary arteries in the complex therapy.
Overdose
If accidentally exceeded daily dose several times may reduce the blood pressure, increased heart rate (pulse), disorientation. Treatment: symptomatic (under medical supervision).
pharmachologic effect
Pharmacological group:
Hepatoprotective agent.
Pharmacological properties:
Combined preparation has hepatoprotective action normalizes all types of metabolism (fat, protein, carbohydrate). Methionine, one of the active components of the product – is an essential amino acid which is a source of mobile methyl groups. Methionine is necessary for the synthesis of choline. Increasing the content of choline promotes increased synthesis of endogenous (internal) phospholipids and decrease neutral fat deposition in the liver. Methionine is also required for neutralization of xenobiotics. When atherosclerosis reduces the concentration of cholesterol and increases the concentration of blood phospholipids.
Essential phospholipids – is essential factors for the development and operation of liver cells. The main fraction of essential phospholipids in the formulation presented phosphatidylcholine (73%), which is the main component of biological membranes. Once in the body, it restores the integrity of membrane phosphatidylcholine infected liver cells and activates fosfolipidzavisimye located in the membrane enzymes, thus normalizing the permeability and increasing detoxification and excretory capacity of the liver cells. Methionine and essential phospholipids enhance the effect of each other, a source of endogenous (internal) and exogenous (ingested) phospholipids, respectively, improve the functional state of the liver cells and exert hepatoprotective (protective) effects.
Methionine is also involved in the metabolism of sulfur-containing amino acids in the synthesis of epinephrine, creatinine, and other biologically active compounds, converts the action of hormones, vitamins (B12, ascorbic, folic acid), enzymes, proteins involved in the reactions peremetilirovaniya, deamination, decarboxylation. Eslidin® restore liver function, increases its detoxification capacity and normalizes fat, carbon and protein metabolism in the body.
Pregnancy and breast-feeding
Eslidina® study confirms the safety of the fetus and the safety of the child during breastfeeding has not been carried out. Use of the drug during pregnancy and lactation is possible only on prescription in cases where the expected benefit to the mother outweighs the potential risk to the fetus and child.
Conditions of supply of pharmacies
Without recipe.
side effects
Allergic reactions.
Storage conditions
Store at a temperature not higher than 25 ° C.
Keep out of the reach of children.
Dosing and Administration
The drug is taken orally, at meal time, swallowing whole with plenty of water.
In liver disease, atherosclerosis, coronary artery and cerebrovascular disease, diabetes, malnutrition and exhaustion take 2 capsules 3 times a day. The recommended course of treatment – 3 months minimum – 1 month.
In psoriasis – 2 capsules 3 times a day. The recommended course of treatment – 2 weeks.
Children older than 7 years for liver diseases, diabetes, fatty liver disease – 2 capsules 3 times a day, for 1 – 3 months.
In psoriasis, children older than 7 years – 2 capsules 3 times a day for 2 weeks.
Use of the drug in children aged 3 to 7 years – 1 capsule 3 times a day for 1-3 months.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist